Dimensional Fund Advisors
NVAX icon

Dimensional Fund Advisors’s Novavax NVAX Stock Holding History

Dimensional Fund Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74M Buy
396,711
+384,864
+3,249% +$3.45M ﹤0.01% 2603
2026
Q1 		$96.4K Buy
11,847
+689
+6% +$6.25K ﹤0.01% 3123
2025
Q4 		$75K Buy
+11,158
New +$84.1K ﹤0.01% 3183
2022
Q3 		– Sell
-10,513
Closed -$541K – 3514
2022
Q2 		$541K Sell
10,513
-52,359
-83% -$2.71M ﹤0.01% 3047
2022
Q1 		$4.63M Sell
62,872
-27,247
-30% -$2.43M ﹤0.01% 2558
2021
Q4 		$12.9M Sell
90,119
-180
-0.2% -$30.9K ﹤0.01% 2200
2021
Q3 		$18.7M Sell
90,299
-12,213
-12% -$2.69M 0.01% 2039
2021
Q2 		$21.8M Buy
102,512
+7,553
+8% +$1.38M 0.01% 2014
2021
Q1 		$17.2M Sell
94,959
-2,231
-2% -$445K 0.01% 2084
2020
Q4 		$10.8M Buy
97,190
+5,090
+6% +$541K ﹤0.01% 2248
2020
Q3 		$9.98M Buy
+92,100
New +$11.2M ﹤0.01% 2194
2015
Q4 		– Sell
-15,272
Closed -$2.16M – 3339
2015
Q3 		$2.16M Buy
+15,272
New +$3.42M ﹤0.01% 2795

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Dimensional Fund Advisors's NVAX Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Novavax (NVAX) stake by 3,249% in Q2 2026, buying an estimated $3.45M and bringing the position to 396,711 shares worth $3.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Dimensional Fund Advisors first reported a position in NVAX in Q3 2015 and has held it in 12 quarters since. The position peaked at $21.8M in Q2 2021. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Dimensional Fund Advisors held 396,711 shares of Novavax worth $3.74M as of Q2 2026.
  • Dimensional Fund Advisors bought 384,864 Novavax shares in Q2 2026, an estimated $3.45M.
  • Novavax made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2603 holding.
  • Dimensional Fund Advisors first reported a position in Novavax in Q3 2015 and has held it in 12 quarters since.
  • Dimensional Fund Advisors's Novavax position peaked at $21.8M in Q2 2021.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.